These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32925085)

  • 1. Natural History of Type 1 Spinal Muscular Atrophy in a Series of Argentinian Children.
    Aguerre V; De Castro F; Mozzoni J; Gravina LP; Araoz HV; Monges S
    J Neuromuscul Dis; 2020; 7(4):453-458. PubMed ID: 32925085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1.
    Fitzgerald DA; Doumit M; Abel F
    Paediatr Respir Rev; 2018 Sep; 28():11-17. PubMed ID: 30414815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival?
    Lemoine TJ; Swoboda KJ; Bratton SL; Holubkov R; Mundorff M; Srivastava R
    Pediatr Crit Care Med; 2012 May; 13(3):e161-5. PubMed ID: 22198810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sleep diagnostics and non-invasive ventilation in children with spinal muscular atrophy.
    Grychtol R; Abel F; Fitzgerald DA
    Paediatr Respir Rev; 2018 Sep; 28():18-25. PubMed ID: 30396824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nusinersen for spinal muscular atrophy type 1: Real-world respiratory experience.
    Lavie M; Diamant N; Cahal M; Sadot E; Be'er M; Fattal-Valevski A; Sagi L; Domany KA; Amirav I
    Pediatr Pulmonol; 2021 Jan; 56(1):291-298. PubMed ID: 33111497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen.
    Sansone VA; Pirola A; Albamonte E; Pane M; Lizio A; D'Amico A; Catteruccia M; Cutrera R; Bruno C; Pedemonte M; Messina S; Rao F; Roma E; Salmin F; Coratti G; Di Bari A; De Sanctis R; Pera CM; Sframeli M; Piastra M; Macagno F; Vita G; Bertini E; Mercuri E
    J Pediatr; 2020 Apr; 219():223-228.e4. PubMed ID: 32035635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician attitudes towards ventilatory support for spinal muscular atrophy type 1 in Australasia.
    Geevasinga N; Ryan MM
    J Paediatr Child Health; 2007 Dec; 43(12):790-4. PubMed ID: 17803671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular atrophy type 1: A noninvasive respiratory management approach.
    Bach JR; Niranjan V; Weaver B
    Chest; 2000 Apr; 117(4):1100-5. PubMed ID: 10767247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen.
    Ergenekon AP; Yilmaz Yegit C; Cenk M; Gokdemir Y; Erdem Eralp E; Ozturk G; Unver O; Kenis Coskun O; Karadag Saygi E; Turkdogan D; Karadag B
    Pediatr Int; 2022 Jan; 64(1):e15175. PubMed ID: 35522792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician driven variation in the care of children with spinal muscular atrophy type 1.
    Oskoui M; Ng P; Liben S; Zielinski D
    Pediatr Pulmonol; 2017 May; 52(5):662-668. PubMed ID: 27685758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival probabilities of patients with childhood spinal muscle atrophy.
    Mannaa MM; Kalra M; Wong B; Cohen AP; Amin RS
    J Clin Neuromuscul Dis; 2009 Mar; 10(3):85-9. PubMed ID: 19258855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory characteristics in children with spinal muscular atrophy type 1 receiving nusinersen.
    Xiao L; Chiang J; Castro-Codesal M; Kolski H; Bedi P; Al Amrani F; Gonorazky HD; Amin R;
    Pediatr Pulmonol; 2023 Jan; 58(1):161-170. PubMed ID: 36193036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nusinersen treatment of spinal muscular atrophy - a systematic review.
    Albrechtsen SS; Born AP; Boesen MS
    Dan Med J; 2020 Aug; 67(9):. PubMed ID: 32800069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory support in spinal muscular atrophy type I: a survey of physician practices and attitudes.
    Hardart MK; Burns JP; Truog RD
    Pediatrics; 2002 Aug; 110(2 Pt 1):e24. PubMed ID: 12165623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of invasive ventilation is appropriate in children with genetically proven spinal muscular atrophy type 1: the motion against.
    Ryan MM
    Paediatr Respir Rev; 2008 Mar; 9(1):51-4; discussion 55-6. PubMed ID: 18280980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study.
    Aragon-Gawinska K; Seferian AM; Daron A; Gargaun E; Vuillerot C; Cances C; Ropars J; Chouchane M; Cuppen I; Hughes I; Illingworth M; Marini-Bettolo C; Rambaud J; Taytard J; Annoussamy M; Scoto M; Gidaro T; Servais L
    Neurology; 2018 Oct; 91(14):e1312-e1318. PubMed ID: 30158155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new respiratory scoring system for evaluation of respiratory outcomes in children with spinal muscular atrophy type1 (SMA1) on SMN enhancing drugs.
    Edel L; Grime C; Robinson V; Manzur A; Abel F; Munot P; Ridout D; Scoto M; Muntoni F; Chan E
    Neuromuscul Disord; 2021 Apr; 31(4):300-309. PubMed ID: 33752934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal muscular atrophy type 1: management and outcomes.
    Bach JR; Baird JS; Plosky D; Navado J; Weaver B
    Pediatr Pulmonol; 2002 Jul; 34(1):16-22. PubMed ID: 12112792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with spinal muscular atrophy type 1.
    Gregoretti C; Ottonello G; Chiarini Testa MB; Mastella C; Ravà L; Bignamini E; Veljkovic A; Cutrera R
    Pediatrics; 2013 May; 131(5):e1509-14. PubMed ID: 23610208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.